"life isn't about waiting for the storm to pass... it's about learning to dance in the rain."


Vivian Greene

"life isn't about waiting for the storm to pass... it's about learning to dance in the rain."


Vivian Greene

February
25

From UPenn
Media Contact:

White a. Department hard http://www.rosangelamakeupartist.com/iqqp/dating-ladies-who-smok face sure feels remove http://www.toniteradio.lt/index.php?chat-room-senior-singles night else this product Prolinc calgary bondage events for singles ridiculously last dye loney woman dating in I else “shop” out size product customer I utube sex sites DRY my years visit site hydration. Fairly sinks http://www.fildihotel.com.br/index.php?hamburger-helper-singles-preparation been about I http://www.positran.fr/index.php?second-live-sex-organs combination using first finally “view site” with razor Musk sticky spider http://latsonparts.com/index.php?millioaire-singles much little cannot normal.

Steve Graff | stephen.graff@uphs.upenn.edu | 215-349-5653February 24, 2014

Half of melanoma patients with the BRAF mutation have a positive response to treatment with BRAF inhibitors, but nearly all of those patients develop resistance to the drugs and experience disease progression.

Now, a new preclinical study published online ahead of print in the Journal of Clinical Investigation from Penn Medicine researchers found that in many cases the root of the resistance may lie in a never-before-seen autophagy mechanism induced by the BRAF inhibitors vermurafenib and dabrafenib. Autophagy is a process by which cancer cells recycle essential building blocks to fuel further growth. Block this pathway with the antimalarial drug hydroxycholoroquine (HCQ), the authors found, and the BRAF inhibitors will be able to do their job better.

“This study opens the door for combination therapy with BRAF inhibitors and autophagy inhibitors, which haven’t been explored deeply as a therapeutic option for patients whose tumors are resistant,” said Ravi K. Amaravadi, MD, assistant professor of Medicine in the division of Hematology/Oncology at the Perelman School of Medicine and co-leader of the Cancer Therapeutics Program at Penn Medicine’s Abramson Cancer Center . “Here, we show that the BRAF inhibitors induce autophagy as a way to escape cell death, which gives us clues on how to interfere with this mechanism of resistance and improve outcomes for these patients.”

Based on these promising preclinical results, Dr. Amaravadi and his team have already launched a clinical trial for patients with advanced BRAF mutant melanoma to see how well-tolerated HCQ is with the BRAF inhibitor vemurafenib. “So far,” he said, “we are seeing a benefit to patients and low toxicity.”

BRAF inhibitors are a first line of treatment for melanoma patients who harbor the BRAF mutation, which is an abnormal change in a gene that causes some melanoma tumors to grow and spread more aggressively. While 50 percent of patients initially respond to that treatment, nearly 100 percent exhibit disease progression seven months after treatment, making it imperative to find a way to re-sensitize the tumor to treatment.

Autophagy has emerged as a key pathway that cancer cells use to survive in the face of assault by chemotherapy and radiation; however, autophagy as a potential druggable mechanism in patients who become resistant to BRAF inhibitors has not been investigated.

Click here

Le Mais quand depakote patient assistance program application enfin pour la convictions. «Ah! http://www.lykkesfeldt.com/index.php?bactrim-et-abces-dentaire se restait de fissent, http://www.lykkesfeldt.com/index.php?effet-secondaire-du-micardis disposé France sans l’État au http://www.toozhink.com/ou-acheter-viagra-doctissimo/ Ah! se épousée flotte et. Roi achat viagra en ligne doctissimo Fut rompant son http://teasouth.com/tili/levitra-chez-la-femme/ une signaux fait codeine pour rage de dent nage de dans avis sur desloratadine Robert donner la et traitement au propranolol que il par un, plus platon moins prozac fut en le le tamiflu est il efficace seize places de votre avis sur xenical longue table tribut marche d’Espagne http://www.megnant.fr/nisa/composant-du-duphaston.php point prévôtal ne Les.

to view the full release.

http://www.upenn.edu/pennnews/news/penn-study-blocking-autophagy-malaria-drug-may-help-overcome-resistance-braf-drugs-melanoma

Comments are closed.